Sort
25,944 grants matching “neurodegeneration”
SLC25A46 mutations cause optic atrophy, axonal neuropathy, and cerebellar neurodegeneration
$390,000Taosheng Huang · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · EY
Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation
$390,000Lin Guo · Thomas Jefferson University · R35 · FY2022 · GM
Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation
$390,000Lin Guo · Thomas Jefferson University · R35 · FY2023 · GM
G-quadruplex DNA in senescence of the neurovascular unit
$390,000Andrey Tsvetkov · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · AG
Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS
$390,000Lin Guo · Thomas Jefferson University · R01 · FY2024 · NS
Neurodegeneration and Microvascular Damage in Alzheimer's Disease
$390,000Jarin Hongpaisan · Thomas Jefferson University · R01 · FY2019 · AG
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS
$390,000Sami Barmada · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Elucidating the mechanisms underlying DNA double-strand break repair
$390,000Michael Soniat · Thomas Jefferson University · R35 · FY2025 · GM
Novel serological biomarkers for BBB dysfunction during HIV-1 infection
$390,000Servio Heybert Ramirez · Temple Univ Of The Commonwealth · R01 · FY2015 · NS
Novel serological biomarkers for BBB dysfunction during HIV-1 infection
$390,000Servio Heybert Ramirez · Temple Univ Of The Commonwealth · R01 · FY2017 · NS
Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation
$390,000Lin Guo · Thomas Jefferson University · R35 · FY2024 · GM
Connecting nuclear functions of Tau with pathology in Alzheimer's disease and other Tauopathies
$390,000Doris Kretzschmar · Oregon Health & Science University · R01 · FY2024 · AG
Neurodegeneration and Microvascular Damage in Alzheimer's Disease
$390,000Jarin Hongpaisan · Thomas Jefferson University · R01 · FY2021 · AG
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS
$390,000Sami Barmada · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
Small molecule targeting of MLK3 for heart failure
$390,000Burns C Blaxall · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · HL
Use of CRISPR/Cas9 to treat Huntington disease
$390,000Stephen T. Warren · Emory University · R21 · FY2018 · NS
Small molecule targeting of MLK3 for heart failure
$390,000Burns C Blaxall · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · HL
Michigan Alzheimer's Disease Core Center
$390,000Henry L Paulson · University Of Michigan At Ann Arbor · P30 · FY2019 · AG
SCA7 NEURODEGENERATION: MOLECULAR BASIS AND THERAPY
$390,000Albert R La Spada · University Of Washington · R01 · FY2007 · EY
Neurodegeneration and Microvascular Damage in Alzheimer's Disease
$390,000Jarin Hongpaisan · Thomas Jefferson University · R01 · FY2022 · AG
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS
$390,000Sami Barmada · University Of Michigan At Ann Arbor · R01 · FY2023 · NS
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALS
$390,000Sami Barmada · University Of Michigan At Ann Arbor · R01 · FY2024 · NS
Neurodegeneration and Microvascular Damage in Alzheimer's Disease
$390,000Jarin Hongpaisan · Thomas Jefferson University · R01 · FY2020 · AG
Neural Stem Cell Transplantation: A Novel Cellular Therapy for Alzheimer's Disease
$390,000Eva L Feldman · University Of Michigan At Ann Arbor · U01 · FY2019 · AG
Interplay between neuroprotective pathways, HIV, and astrocytes
$389,918Lena Al-Harthi · Rush University Medical Center · R01 · FY2008 · NS